InvestorsHub Logo

kenyboy

09/14/18 10:45 AM

#142230 RE: dV1 #142173

This is just my opinion as Jelis could not prove statistically
Significant reduction in cardiac death using 18,000 enrolees.
Amarin is using only 8175 enrolees in 11 countries. I would be ecstatic if
Reduce-IT can do it. My only hope is a riskier population in Reduce-IT than Jelis
May make a difference but I am not convinced......